tiprankstipranks
Trending News
More News >
Nervgen Pharma Corp (NGENF)
:NGENF
US Market
Advertisement

NervGen Pharma (NGENF) Technical Analysis

Compare
59 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Nervgen Pharma Corp’s (NGENF) Moving Averages Convergence Divergence (MACD) indicator is 0.03, suggesting Nervgen Pharma Corp is a Sell.
Nervgen Pharma Corp’s (NGENF) 20-Day exponential moving average is 2.75, while Nervgen Pharma Corp’s (NGENF) share price is $2.84, making it a Buy.
Nervgen Pharma Corp’s (NGENF) 50-Day exponential moving average is 2.71, while Nervgen Pharma Corp’s (NGENF) share price is $2.84, making it a Buy.

NervGen Pharma (NGENF) Pivot Points

Jul 18, 2025, 10:28 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.65
2.72
2.78
2.86
2.92
2.99
3.05
Fibonacci
2.72
2.78
2.81
2.86
2.91
2.94
2.99
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NervGen Pharma (NGENF) Moving Averages

Jul 18, 2025, 10:28 AM
Period
Simple
Exponential
MA5
2.89Sell
2.83Sell
MA10
2.77Sell
2.79Sell
MA20
2.69Buy
2.75Buy
MA50
2.89Sell
2.71Buy
MA100
2.46Buy
2.55Buy
MA200
2.19Buy
2.32Buy
Nervgen Pharma Corp’s (NGENF) 10-Day exponential moving average is 2.79, while Nervgen Pharma Corp’s (NGENF) share price is $2.84, making it a Sell.
Nervgen Pharma Corp’s (NGENF) 100-Day exponential moving average is 2.55, while Nervgen Pharma Corp’s (NGENF) share price is $2.84, making it a Buy.
Nervgen Pharma Corp’s (NGENF) stock price is $2.84 and Nervgen Pharma Corp’s (NGENF) 50-day simple moving average is 2.89, creating a Sell signal.
Nervgen Pharma Corp’s (NGENF) stock price is $2.84 and Nervgen Pharma Corp’s (NGENF) 100-day simple moving average is 2.46, creating a Buy signal.
Nervgen Pharma Corp’s (NGENF) stock price is $2.84 and Nervgen Pharma Corp’s (NGENF) 200-day simple moving average is 2.19, creating a Buy signal.

NervGen Pharma (NGENF) Technical Indicators

Jul 18, 2025, 10:28 AM
Name
Value
Implied Action
RSI (14)
50.32
Neutral
STOCH (9,6)
56.38
Neutral
STOCHRSI (14)
59.56
Neutral
MACD (12,26)
0.03
Sell
ADX (14)
14.74
Buy
Williams %R
-50.67
Buy
CCI (14)
28.01
Neutral
ATR (14)
0.24
-
Ultimate Oscillator
47.42
Neutral
ROC
1.85
Buy
Nervgen Pharma Corp’s (NGENF) Relative Strength Index (RSI) is 50.32, creating a Neutral signal.
Nervgen Pharma Corp’s (NGENF) Trend Strength Indicator (ADX) is 14.74, creating a Buy signal.
Nervgen Pharma Corp’s (NGENF) Commodity Channel Index (CCI) is 28.01, creating a Neutral signal.
Nervgen Pharma Corp’s (NGENF) Price Rate of Change (ROC) is 1.85, creating a Buy signal.

FAQ

Is NGENF a Buy, Hold, or Sell?
Based on NGENF’s technical indicators, NGENF is a Buy.
    What is NGENF’s RSI (14)?
    NGENF’s RSI (14) is 50.32, which suggests NGENF is a Neutral.
      What is NGENF’s MACD?
      NGENF’s MACD is 0.03, which suggests NGENF is a Sell.
        What is NGENF’s 5-day moving average?
        NGENF’s 5-day moving average is 2.89, which suggests NGENF is a Sell.
          What is NGENF’s 20-day moving average?
          NGENF 20-day moving average is 2.69, which suggests NGENF is a Buy.
            What is NGENF’s 50-day moving average?
            NGENF’s 50-day moving average is 2.89, which suggests NGENF is a Sell.
              What is NGENF’s 200-day moving average?
              NGENF’s 200-day moving average is 2.19, which suggests NGENF is a Buy.
                What is NGENF’s Williams % R (14)?
                NGENF’s Williams % R (14) is -50.67, which suggests NGENF is a Buy.
                  What is NGENF’s CCI (14)?
                  NGENF’s CCI (14) is 28.01, which suggests NGENF is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis